Clinical Trials
2 trialsNCT00109967 2014-04-17
CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00033267 2014-04-03
CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma
National Cancer Institute (NCI)
Phase 2 Completed